Celsius Announces Pricing of Public Offering of Common Stock
Celsius Holdings, Inc. (Nasdaq: CELH) announced a public offering of 6,518,267 common stock shares priced at $62.50 each. This includes 5,518,267 shares from selling stockholders and 1,000,000 shares from Celsius. A 30-day option for underwriters to purchase an additional 977,740 shares is also granted. Celsius will not receive proceeds from the selling stockholders' shares and plans to utilize its net proceeds for general corporate purposes. The offering is expected to close on June 14, 2021.
- Public offering of 1,000,000 shares by Celsius could provide liquidity for future growth.
- Underwriters have the option to purchase an additional 977,740 shares, which may indicate strong demand.
- Celsius will not receive any proceeds from the sale of shares by selling stockholders, potentially limiting direct capital influx.
- Potential dilution of existing shareholders' equity due to the large number of shares being offered.
BOCA RATON, Fla., June 9, 2021 /PRNewswire/ -- (Nasdaq: CELH) Celsius Holdings, Inc., maker of global fitness drink, CELSIUS®, today announced the pricing of a public offering of 6,518,267 shares of common stock, consisting of 5,518,267 shares of common stock offered by certain selling stockholders of Celsius Holdings (the "Selling Stockholders") and 1,000,000 shares of common stock offered by Celsius Holdings at a public offering price of
Celsius Holdings will not receive any proceeds from the sale of the shares by the Selling Stockholders and intends to use the net proceeds received by it from the offering for general corporate purposes. The offering is expected to close on June 14, 2021, subject to customary closing conditions.
UBS Investment Bank and Jefferies are serving as joint book-running managers for the offering. B. Riley Securities, Ladenburg Thalmann & Co. Inc., Maxim Group LLC and Roth Capital Partners are serving as co-managers for the offering.
The public offering is being made pursuant to an automatic shelf registration statement on Form S-3, which was filed with the Securities and Exchange Commission (the "SEC") on June 9, 2021, and became automatically effective upon filing. The public offering is being made only by means of a prospectus supplement and accompanying prospectus, copies of which may be obtained on the SEC's website located at http://www.sec.gov. Copies of the final prospectus supplement and the accompanying base prospectus relating to the offering may also be obtained, when available, from:
- UBS Securities LLC, Attention: Prospectus Department, 1285 Avenue of the Americas, New York, NY 10019, telephone: 888-827-7275 or email: ol-prospectusrequest@ubs.com; or
- Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, or by calling (877) 821-7388, or by emailing prospectus_department@jefferies.com.
This press release shall not constitute an offer to sell or a solicitation of an offer to buy the securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Celsius Holdings, Inc.
Celsius Holdings, Inc. (Nasdaq: CELH), is a fast-growing company in the functional energy drink and supplement categories in the United States and internationally, engaged in the development, marketing, sale, and distribution of functional calorie-burning supplements that offer clinically proven and innovative formulas meant to improve the health and wellness of our consumers. CELSIUS® has five beverage lines that include, CELSIUS® Originals, CELSIUS HEAT™, CELSIUS® BCAA +Energy, CELSIUS® On-the-Go, and CELSIUS® Sweetened with Stevia. CELSIUS® has zero sugar, no preservatives, no aspartame, no high fructose corn syrup, and is non-GMO, with no artificial flavors or colors. The CELSIUS® line of products is Certified Kosher and Vegan. CELSIUS® is also soy and gluten-free and contains very little sodium.
Forward-Looking Statements
This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements contain projections of Celsius Holdings' future results of operations and/or financial position, or state other forward-looking information. In some cases, you can identify these statements by forward-looking words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," "will," "would," or similar words. You should not rely on forward-looking statements since Celsius Holdings' actual results may differ materially from those indicated by forward-looking statements as a result of a number of important factors. These factors include, but are not limited to: general economic and business conditions; our business strategy for expanding our presence in our industry; anticipated trends in our financial condition and results of operation; the impact of competition and technology change; existing and future regulations affecting our business; and other risks and uncertainties discussed in the reports Celsius Holdings has filed previously with the Securities and Exchange Commission. Celsius Holdings does not intend to and undertakes no duty to update the information contained in this press release.
Investor Relations:
Cameron Donahue
(651) 707-3532
cdonahue@celsius.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/celsius-announces-pricing-of-public-offering-of-common-stock-301309595.html
SOURCE Celsius Holdings, Inc.
FAQ
What is the public offering price of CELH shares?
How many shares are being offered in the Celsius Holdings public offering?
When is the expected closing date for the CELH stock offering?
Who are the underwriters for the Celsius Holdings offering?
How will Celsius Holdings use the proceeds from the offering?
